Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
Deepak Garg, Valliappan Muthu, Inderpaul Singh Sehgal, et al.
Mycopathologia (2021) Vol. 186, Iss. 2, pp. 289-298
Open Access | Times Cited: 559

Showing 1-25 of 559 citing articles:

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
Awadhesh Kumar Singh, Ritu Singh, Shashank Joshi, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102146-102146
Open Access | Times Cited: 992
Tackling the emerging threat of antifungal resistance to human health
Matthew C. Fisher, Ana Alastruey‐Izquierdo, Judith Berman, et al.
Nature Reviews Microbiology (2022) Vol. 20, Iss. 9, pp. 557-571
Open Access | Times Cited: 655
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Teny John, Ceena Neena Jacob, Dimitrios P. Kontoyiannis
Journal of Fungi (2021) Vol. 7, Iss. 4, pp. 298-298
Open Access | Times Cited: 481
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
Kamalesh Kumar Patel, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 9, pp. 2349-2359
Open Access | Times Cited: 421
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Martin Hoenigl, Danila Seidel, Agostinho Carvalho, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 7, pp. e543-e552
Open Access | Times Cited: 387
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Rimesh Pal, Birgurman Singh, Sanjay Kumar Bhadada, et al.
Mycoses (2021) Vol. 64, Iss. 12, pp. 1452-1459
Open Access | Times Cited: 244
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, et al.
Mycopathologia (2021) Vol. 186, Iss. 6, pp. 739-754
Open Access | Times Cited: 201
Mucormycosis: An opportunistic pathogen during COVID-19
Mahalaxmi Iyer, Kaavya Jayaramayya, Dhivya Venkatesan, et al.
Environmental Research (2021) Vol. 201, pp. 111643-111643
Open Access | Times Cited: 179
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
Shivaprakash M. Rudramurthy, Martin Hoenigl, Jacques F. Meis, et al.
Mycoses (2021) Vol. 64, Iss. 9, pp. 1028-1037
Open Access | Times Cited: 175
Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Lav Selarka, Suktara Sharma, Dinesh Kumar Saini, et al.
Mycoses (2021) Vol. 64, Iss. 10, pp. 1253-1260
Open Access | Times Cited: 164
COVID-19 and mucormycosis superinfection: the perfect storm
Jaffar A. Al‐Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 833-853
Open Access | Times Cited: 156
COVID-19-associated opportunistic infections: a snapshot on the current reports
Amir Abdoli, Shahab Falahi, Azra Kenarkoohi
Clinical and Experimental Medicine (2021) Vol. 22, Iss. 3, pp. 327-346
Open Access | Times Cited: 129
A Review of Coronavirus Disease Covid-19
Swapnali Zore
International Journal of Advanced Research in Science Communication and Technology (2021), pp. 104-115
Open Access | Times Cited: 119
COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic’s second wave in India
Jesil Mathew Aranjani, Atulya Manuel, Habeeb Ibrahim Abdul Razack, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 11, pp. e0009921-e0009921
Open Access | Times Cited: 106
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
Valliappan Muthu, Ritesh Agarwal, Atul Patel, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. e240-e253
Open Access | Times Cited: 67
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
Valliappan Muthu, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 1, pp. 8-19
Open Access | Times Cited: 46
Fungal Drug Response and Antimicrobial Resistance
Paloma Osset-Trénor, Amparo Pascual‐Ahuir, Markus Proft
Journal of Fungi (2023) Vol. 9, Iss. 5, pp. 565-565
Open Access | Times Cited: 43
Coronavirus Disease 2019–Associated Invasive Fungal Infection
John W. Baddley, George R. Thompson, Sharon C.‐A. Chen, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 12
Open Access | Times Cited: 98
COVID-19-associated mucormycosis: Case report and systematic review
Ahmet Dilek, Reşat Özaras, Şevket Özkaya, et al.
Travel Medicine and Infectious Disease (2021) Vol. 44, pp. 102148-102148
Open Access | Times Cited: 85
Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections
Ke Peng, Lalitkumar K. Vora, Ismaiel A. Tekko, et al.
Journal of Controlled Release (2021) Vol. 339, pp. 361-380
Open Access | Times Cited: 84
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
Giacomo Casalini, Andrea Giacomelli, Annalisa Ridolfo, et al.
Journal of Fungi (2021) Vol. 7, Iss. 11, pp. 921-921
Open Access | Times Cited: 82
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
Maryam Roudbary, Sunil Kumar, Awanish Kumar, et al.
Journal of Fungi (2021) Vol. 7, Iss. 9, pp. 720-720
Open Access | Times Cited: 81
Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review
Anson Jose, Shagun Singh, Ajoy Roychoudhury, et al.
Journal of Maxillofacial and Oral Surgery (2021) Vol. 20, Iss. 3, pp. 373-380
Open Access | Times Cited: 77
Molecular Docking Studies on the Anti-Fungal Activity of Allium Sativum (Garlic) Against Mucormycosis (Black Fungus) by BIOVIA Discovery Studio Visualizer 21.1.0.0
Shaweta Sharma, Akhil Sharma, Utsav Gupta
Research Square (Research Square) (2021)
Open Access | Times Cited: 72
Mucormycosis in COVID-19 pandemic: Risk factors and linkages
Manoj Kumar, Devojit Kumar Sarma, Swasti Shubham, et al.
Current Research in Microbial Sciences (2021) Vol. 2, pp. 100057-100057
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top